Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 3 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready
Dr. Reddy's Laboratories Limited has 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are spread across 2 distinct art units and involve 3 distinct examiners. Mohammad Y Meah is the busiest examiner for the portfolio, currently managing 1 pending office action. The distribution of actions among different examiners suggests that each application is being evaluated independently, requiring unique responses for each case despite the shared technology area. The 2 art units represent the technical divisions involved in the review.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (17%) |
| Double-patenting + other | 2 (33%) |
| Multi-statute (no §101) | 3 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BAZARGANI, ARYA AHMADI | 1 | 62.5% | +31.3% |
| DRISCOLL, MAUREEN VARINA | 1 | 63.7% | +40.8% |
| LANDSMAN, ROBERT S | 1 | 81.3% | +13.0% |
| VAN DRUFF, SYDNEY | 1 | 55.0% | +31.7% |
| TAYLOR, LIA ELAN | 1 | 64.4% | +29.4% |
| GURLEY, JAMI MICHELLE | 1 | 53.3% | +16.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18681162 | Method To Purify An Antibody Composition Using Cation Exchange Chromatography | LANDSMAN, ROBERT S | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19049310 | LIQUID INJECTABLE COMPOSITIONS OF LURBINECTEDIN | BAZARGANI, ARYA AHMADI | — |
| 18685082 | A PROCESS TO PRODUCE A PHARMACEUTICAL COMPOSITION | DRISCOLL, MAUREEN VARINA | — |
| 18291909 | Method To Control High Molecular Weight Aggregates In An Antibody Composition | VAN DRUFF, SYDNEY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19049310 | LIQUID INJECTABLE COMPOSITIONS OF LURBINECTEDIN | BAZARGANI, ARYA AHMADI | — |
| 18685082 | A PROCESS TO PRODUCE A PHARMACEUTICAL COMPOSITION | DRISCOLL, MAUREEN VARINA | — |
| 18681162 | Method To Purify An Antibody Composition Using Cation Exchange Chromatography | LANDSMAN, ROBERT S | — |
| 18291909 | Method To Control High Molecular Weight Aggregates In An Antibody Composition | VAN DRUFF, SYDNEY | — |
| 18273142 | FREEZE DRIED ANTIBODY FORMULATIONS AND METHODS THEREOF | TAYLOR, LIA ELAN | — |
| 18038282 | STABLE THERAPEUTIC PROTEIN FORMULATION AND METHODS OF MAKING THE SAME | GURLEY, JAMI MICHELLE | — |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| 1641 | 1 |
| 1647 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19049310 | LIQUID INJECTABLE COMPOSITIONS OF LURBINECTEDIN | BAZARGANI, ARYA AHMADI | 1615 | §103§112 | Non-Final OA | — | Pending | Feb 10, 2025 |
| 18685082 | A PROCESS TO PRODUCE A PHARMACEUTICAL COMPOSITION | DRISCOLL, MAUREEN VARINA | — | §103§112 | Non-Final OA | — | Pending | Feb 20, 2024 |
| 18681162 | Method To Purify An Antibody Composition Using Cation Exchange Chromatography | LANDSMAN, ROBERT S | — | §102§112DP | Non-Final OA | — | Pending | Feb 05, 2024 |
| 18291909 | Method To Control High Molecular Weight Aggregates In An Antibody Composition | VAN DRUFF, SYDNEY | — | §102§103 | Non-Final OA | — | Pending | Jan 24, 2024 |
| 18273142 | FREEZE DRIED ANTIBODY FORMULATIONS AND METHODS THEREOF | TAYLOR, LIA ELAN | 1641 | §103§112DP | Non-Final OA | — | Pending | Jul 19, 2023 |
| 18038282 | STABLE THERAPEUTIC PROTEIN FORMULATION AND METHODS OF MAKING THE SAME | GURLEY, JAMI MICHELLE | 1647 | §103 | Non-Final OA | — | Pending | May 23, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial